Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Micro and Macro Vascular Dysfunction Induced by Antiangiogenic Therapy: Identification of New Vascular Biomarkers (DYVA-AAGG)

NCT02161978 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02161978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Micro and Macro Vascular Dysfunction Induced by Antiangiogenic Therapy: Identification of New Vascular Biomarkers (DYVA-AAGG)
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Completed
Start date
February 9, 2012
Completion date
December 12, 2018
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cml (chronic myelogenous leukemia), endothelial dysfunction, solid tumor, tumor angiogenesis